Frequency Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FREQ and buy or sell other stocks, ETFs, and their options commission-free!About FREQ
Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B.
CEORam Aiyar, PhD, MBA
CEORam Aiyar, PhD, MBA
Employees104
Employees104
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees104
Employees104
FREQ Key Statistics
Market cap564.91M
Market cap564.91M
Price-Earnings ratio-1.12
Price-Earnings ratio-1.12
Dividend yield—
Dividend yield—
Average volume179.52K
Average volume179.52K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$55.89
52 Week high$55.89
52 Week low$5.20
52 Week low$5.20
Stock Snapshot
Frequency Therapeutics(FREQ) stock is priced at $60.11, giving the company a market capitalization of 564.91M. It carries a P/E multiple of -1.12.
On 2026-01-23, Frequency Therapeutics(FREQ) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Frequency Therapeutics(FREQ) stock has reached 0, versus its average volume of 179.52K.
Over the past 52 weeks, Frequency Therapeutics(FREQ) stock has traded between a high of $55.89 and a low of $5.20.
Over the past 52 weeks, Frequency Therapeutics(FREQ) stock has traded between a high of $55.89 and a low of $5.20.
People also own
Based on the portfolios of people who own FREQ. This list is generated using Robinhood data, and it’s not a recommendation.